2022 saw a record number of new companies join the fold, unprecedented government support, and a continued expansion of alternative protein products hitting the market.
GFI experts respond to FDAs “no questions” letter issued to GOOD Meat, marking the first time a cultivated meat product has received regulatory approval on multiple continents.
GFI celebrates milestone FDA decision, which paves the way for consumers to purchase meat cultivated directly from animal cells in the U.S. for the very first time.
GFI, Animal Legal Defense Fund, and the ACLU have secured a court order that finds an Arkansas food label censorship law unconstitutional and permanently blocks enforcement of the law against Tofurky.
FAIRR and GFI launch new first-of-their-kind reporting frameworks for alternative meat, seafood, eggs and dairy companies to reveal their climate, biodiversity, nutrition and other ESG impacts.
GFI calls for increased public funding for alternative proteins as the world’s top scientists recognize that agricultural innovation — specifically plant-based and cultivated meat — mitigates climate change, delivers co-benefits in the areas of biodiversity and global health.
The U.S. District Court for the Middle District of Louisiana has granted a motion for summary judgment, halting enforcement of a labeling law in favor of Tofurky.
New data shows consumers turning to plant-based amidst supply chain volatility and inflation.
2021 was a record period for alternative protein investments globally, with $5 billion raised by companies creating sustainable alternatives to conventional animal-based foods.
Ilya Sheyman will join GFI as President on February 22, to lead all aspects of GFI-U.S.’s programmatic and administrative operations.
